Fairvalue-Calculator Fairvalue-Calculator
EN DE

Chongqing Zhifei Biological Products Co (300122) Fair Value & Analysis

Healthcare · CN · Market cap 29.9B CNY

Price¥12.31
Fair Value¥7.52
Upside-38.9%
Quality94/100
Evidence: Medium Range ¥4.15 – ¥10.89

Fair value as of: Jun 25, 2026

Analysis

Chongqing Zhifei Biological Products Co (300122) currently trades at ¥12.31, while our model-based Fair Value estimate is ¥7.52 — implying the stock looks roughly 38.9% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine. It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines. The company was founded in 2002 and is based in Chongqing, China.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Chongqing Zhifei Biological Products Co (300122) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥7.52 versus a price of ¥12.31 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 300122?
Our 21-model fair value for Chongqing Zhifei Biological Products Co is ¥7.52 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥12.31.
What is the quality score of 300122?
Chongqing Zhifei Biological Products Co has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.